Niek J de Wit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Niek J de Wit has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- A Otto Quartero
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
3 shared publications - Me Numans
Universitair Medisch Centrum Utrecht, Julius Centrum voor Patiënt-gebonden Onderzoek, Postbus 85060, 3808 AB Utrecht
3 shared publications A J Smout
1 shared publicationA P Zuithoff
1 shared publicationA. J. P. M. Smout
Department of Gastroenterology, University Medical Center, Utrecht, The Netherlands
1 shared publicationA. O. Puartero Quartero
Department of General Practice, University Medical Centre, Utrecht, The Netherlands
1 shared publication
Latest Publications
- 21 July 2004
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (4) , 451-458
Treatment of gastro‐oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
The presence of the gastric pathogen, Helicobacter pylori influences acid suppression by proton pump inhibitors and treatment outcome in patients with gastro-oesophageal reflux disease. To determine the influence of H. pylori infection on effectiveness of rabeprazole in primary and secondary care patients with gastro-oesophageal reflux disease. Patients from primary and secondary care centres with uninvestigated gastro-oesophageal reflux disease (based on symptoms only) and investigated gastro-oesophageal reflux disease (endoscopically confirmed oesophagitis or endoscopy-negative reflux disease) were tested for H. pylori and treated with rabeprazole 20 mg once daily for 4-8 weeks in a non-randomized, multicentre, open-label study. Primary end-point for treatment effectiveness was complete resolution of both heartburn and acid regurgitation at 4-8 weeks; secondary end-point was quality of life as registered with the Psychological General Well-being Index. Data of 1787 patients could be analysed; mean duration of treatment was 36.3 days. At the evaluation visit 76.9% were heartburn-free, 77.7% regurgitation-free and 71% had complete symptom resolution. Overall Psychological General Well-being Index scores improved accordingly. Treatment was equally effective in patients with or without H. pylori infection, but more effective in patients with oesophagitis when compared with symptomatic gastro-oesophageal reflux disease. The effectiveness of rabeprazole in gastro-oesophageal reflux disease is not affected by the presence of H. pylori infection.
- 21 July 2004
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (4) , 451-458
Treatment of gastro‐oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
The presence of the gastric pathogen, Helicobacter pylori influences acid suppression by proton pump inhibitors and treatment outcome in patients with gastro-oesophageal reflux disease. To determine the influence of H. pylori infection on effectiveness of rabeprazole in primary and secondary care patients with gastro-oesophageal reflux disease. Patients from primary and secondary care centres with uninvestigated gastro-oesophageal reflux disease (based on symptoms only) and investigated gastro-oesophageal reflux disease (endoscopically confirmed oesophagitis or endoscopy-negative reflux disease) were tested for H. pylori and treated with rabeprazole 20 mg once daily for 4-8 weeks in a non-randomized, multicentre, open-label study. Primary end-point for treatment effectiveness was complete resolution of both heartburn and acid regurgitation at 4-8 weeks; secondary end-point was quality of life as registered with the Psychological General Well-being Index. Data of 1787 patients could be analysed; mean duration of treatment was 36.3 days. At the evaluation visit 76.9% were heartburn-free, 77.7% regurgitation-free and 71% had complete symptom resolution. Overall Psychological General Well-being Index scores improved accordingly. Treatment was equally effective in patients with or without H. pylori infection, but more effective in patients with oesophagitis when compared with symptomatic gastro-oesophageal reflux disease. The effectiveness of rabeprazole in gastro-oesophageal reflux disease is not affected by the presence of H. pylori infection.
- 1 February 2003
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 46 (2) , 901-906
Terminale zorg aan oncologische patiënten in de huisartsenpraktijk; frequentie, inhoud en ervaren belasting
- 1 February 2003
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 46 (2) , 901-906
Terminale zorg aan oncologische patiënten in de huisartsenpraktijk; frequentie, inhoud en ervaren belasting
- Open Access
- 1 January 2003
- Published by Hindawi Limited in Canadian Journal of Gastroenterology and Hepatology
- Vol. 17 (6) , 363-368
Irritable Bowel Syndrome in Primary Care: The Patients’ and Doctors’ Views on Symptoms, Etiology and Management
BACKGROUND: To facilitate the development of clinical guidelines and to direct future irritable bowel syndrome (IBS) research, insight into the perceptions of patients and general practitioners (GPs) regarding IBS is required.OBJECTIVES : To compare patients’ and GPs’ views on the symptomatology, etiology and treatment of IBS. METHODS: One hundred forty-two IBS patients and 100 GPs were requested to complete a structured questionnaire.RESULTS: The response rates of the patients and GPs were 80% and 47%, respectively. Abdominal pain and bloating were considered to be the most bothersome symptoms in IBS, by both patients and GPs. Although all patients were diagnosed by their GP as having IBS, and 62% met the Manning criteria, only 18% fulfilled the Rome II criteria for IBS. Patients consider food intolerance and GPs regard lack of fibre as the main etiologic dietary factor. Many IBS patients expect a diagnostic work-up, but GPs generally restrict this to elderly patients. GPs start IBS management with dietary advice (94%), counselling (77%) and drug therapy (55%). Patients expect reassurance (47%) and drug treatment (37%), but dietary interventions are less appreciated (9%).CONCLUSIONS: Patients and GPs have different perceptions of the efficacy of diagnostic and dietary interventions in IBS. GPs should explore the patients expectations and incorporate these in their approach to IBS patients.
- 1 January 2003
- Published by Hindawi Limited in Canadian Journal of Gastroenterology and Hepatology
- Vol. 17 (6) , 363-368
Open AccessIrritable Bowel Syndrome in Primary Care: The Patients’ and Doctors’ Views on Symptoms, Etiology and Management
BACKGROUND: To facilitate the development of clinical guidelines and to direct future irritable bowel syndrome (IBS) research, insight into the perceptions of patients and general practitioners (GPs) regarding IBS is required.OBJECTIVES : To compare patients’ and GPs’ views on the symptomatology, etiology and treatment of IBS. METHODS: One hundred forty-two IBS patients and 100 GPs were requested to complete a structured questionnaire.RESULTS: The response rates of the patients and GPs were 80% and 47%, respectively. Abdominal pain and bloating were considered to be the most bothersome symptoms in IBS, by both patients and GPs. Although all patients were diagnosed by their GP as having IBS, and 62% met the Manning criteria, only 18% fulfilled the Rome II criteria for IBS. Patients consider food intolerance and GPs regard lack of fibre as the main etiologic dietary factor. Many IBS patients expect a diagnostic work-up, but GPs generally restrict this to elderly patients. GPs start IBS management with dietary advice (94%), counselling (77%) and drug therapy (55%). Patients expect reassurance (47%) and drug treatment (37%), but dietary interventions are less appreciated (9%).CONCLUSIONS: Patients and GPs have different perceptions of the efficacy of diagnostic and dietary interventions in IBS. GPs should explore the patients expectations and incorporate these in their approach to IBS patients.
- 1 September 2002
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 45 (9) , 320-325
Diarreeanamnese buikpijn diarree infectieziekten irritable bowel syndrome laboratoriumonderzoek lichamelijk onderzoek prikkelbare darm
- 1 September 2002
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 45 (9) , 320-325
Diarreeanamnese buikpijn diarree infectieziekten irritable bowel syndrome laboratoriumonderzoek lichamelijk onderzoek prikkelbare darm
- 1 November 2001
- Vol. 50 (11) , 976
Participation and successful patient recruitment in primary care.
The demand for family physicians (FPs) to participate in research is growing. The delicate balance between research participation and the daily practice routine might explain the often-disappointing number of patients recruited. We analyzed practice and physician characteristics associated with successful patient recruitment. We used a survey to conduct this study. There was a total of 165 FPs who participated in a combined randomized clinical trial/cohort study on drug treatment of dyspepsia in the Netherlands. We surveyed FPs about personal and practice characteristics and their motivation for participation in the project. These data were then related to the number of patients recruited. Univariate associations were calculated; relevant factors were entered into a logistic model that predicted patient recruitment. Data on 128 FPs could be analyzed (80% response rate); these FPs recruited 793 patients in the cohort study (mean = 6.3 per FP) and 527 in the clinical trial (mean = 4.2 per FP). The main reasons for participation were the research topic (59%) and the participation of an academic research group in the study (63%). Many FPs felt that participation was a professional obligation (39%); the financial incentive played a minor role (15%). The number of recruited patients was only independently associated with the participation of an academic research group. Successful patient recruitment in primary care research is determined more by motivation driven by the research group than by financial incentives, the research topic, or research experience.
- 1 November 2001
- Vol. 50 (11) , 976
Participation and successful patient recruitment in primary care.
The demand for family physicians (FPs) to participate in research is growing. The delicate balance between research participation and the daily practice routine might explain the often-disappointing number of patients recruited. We analyzed practice and physician characteristics associated with successful patient recruitment. We used a survey to conduct this study. There was a total of 165 FPs who participated in a combined randomized clinical trial/cohort study on drug treatment of dyspepsia in the Netherlands. We surveyed FPs about personal and practice characteristics and their motivation for participation in the project. These data were then related to the number of patients recruited. Univariate associations were calculated; relevant factors were entered into a logistic model that predicted patient recruitment. Data on 128 FPs could be analyzed (80% response rate); these FPs recruited 793 patients in the cohort study (mean = 6.3 per FP) and 527 in the clinical trial (mean = 4.2 per FP). The main reasons for participation were the research topic (59%) and the participation of an academic research group in the study (63%). Many FPs felt that participation was a professional obligation (39%); the financial incentive played a minor role (15%). The number of recruited patients was only independently associated with the participation of an academic research group. Successful patient recruitment in primary care research is determined more by motivation driven by the research group than by financial incentives, the research topic, or research experience.
- Open Access
- 22 August 2001
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (8) , 1205-1210
Helicobacter pylori testing in the primary care setting: which diagnostic test should be used?
Aim : To identify the most accurate and efficient test for diagnosing Helicobacter pylori infection in primary care patients. Study design : A whole blood test, an ELISA, and carbon13 urea breath test (CUBT) were evaluated in a primary care setting and validated against two different gold standards that used gastric biopsies. Population : Primary care patients who had dyspeptic complaints lasting at least 2 weeks and were referred for endoscopy. Outcomes measured : Positive and negative predictive values, sensitivity and specificity were determined for all three noninvasive H. pylori tests. Results : Data from the three non‐invasive H. pylori tests were available for 136 primary care dyspeptic patients referred for endoscopy. They were compared with data from the gold standards. The positive predictive value of the whole blood test was in the range 71–75%, the ELISA 83–86%, and the CUBT 88–92%, while the negative predictive values were in the ranges 72–77%, 96–100%, and 95–98%, respectively. The sensitivity of the whole blood test was in the range 36–42%, the ELISA 93–100%, and the CUBT 92–97%, while the specificities were in the ranges 92–93%, 90–91% and 93–95%, respectively. The positive predictive value of the ELISA dropped significantly at lower H. pylori infection rates. Discussion : Both the ELISA and CUBT are effective in the primary care setting, while the whole blood tests produces inferior results. ELISA might, however, be less suitable for detecting H. pylori infection in a population with a low rate of infection.
- 22 August 2001
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (8) , 1205-1210
Open AccessHelicobacter pylori testing in the primary care setting: which diagnostic test should be used?
Aim : To identify the most accurate and efficient test for diagnosing Helicobacter pylori infection in primary care patients. Study design : A whole blood test, an ELISA, and carbon13 urea breath test (CUBT) were evaluated in a primary care setting and validated against two different gold standards that used gastric biopsies. Population : Primary care patients who had dyspeptic complaints lasting at least 2 weeks and were referred for endoscopy. Outcomes measured : Positive and negative predictive values, sensitivity and specificity were determined for all three noninvasive H. pylori tests. Results : Data from the three non‐invasive H. pylori tests were available for 136 primary care dyspeptic patients referred for endoscopy. They were compared with data from the gold standards. The positive predictive value of the whole blood test was in the range 71–75%, the ELISA 83–86%, and the CUBT 88–92%, while the negative predictive values were in the ranges 72–77%, 96–100%, and 95–98%, respectively. The sensitivity of the whole blood test was in the range 36–42%, the ELISA 93–100%, and the CUBT 92–97%, while the specificities were in the ranges 92–93%, 90–91% and 93–95%, respectively. The positive predictive value of the ELISA dropped significantly at lower H. pylori infection rates. Discussion : Both the ELISA and CUBT are effective in the primary care setting, while the whole blood tests produces inferior results. ELISA might, however, be less suitable for detecting H. pylori infection in a population with a low rate of infection.
- 1 October 1999
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (10) , 1317-1321
Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease: the effectiveness of case‐finding in general practice
Maintenance therapy with acid-inhibiting medication is common in general practice. Since the eradication of Helicobacter pylori has become the treatment of choice for peptic ulcer disease, H. pylori treatment could replace maintenance therapy in patients with an ulcer history. To determine the effectiveness of a full peptic ulcer disease history case-finding strategy, together with subsequent H. pylori testing and treatment, in discontinuing maintenance therapy. Patients were included from seven general practices, who had been using acid-inhibiting medication for more than 3 months in the period May 1996-May 1997. Patients with a history of proven peptic ulcer disease were tested, and treated with proton pump inhibitor-triple therapy if positive. Maintenance therapy was discontinued and restart within 12 months was monitored. Long-term acid suppression was used by 2.8% of the practice-populations. A peptic ulcer disease history was found in 18% of the patients, 73% of whom were offered the 'H. pylori test and treat' alternative. The majority responded: 92% of the H. pylori-infected patients were treated, 78% of whom successfully discontinued long-term medication. Implementing an 'H. pylori test and treat' strategy enabled one-third of the patients with a peptic ulcer disease history to stop maintenance therapy successfully. The strategy contributes to reduction of long-term drug use, but compliance needs improvement.
- 1 October 1999
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (10) , 1317-1321
Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease: the effectiveness of case‐finding in general practice
Maintenance therapy with acid-inhibiting medication is common in general practice. Since the eradication of Helicobacter pylori has become the treatment of choice for peptic ulcer disease, H. pylori treatment could replace maintenance therapy in patients with an ulcer history. To determine the effectiveness of a full peptic ulcer disease history case-finding strategy, together with subsequent H. pylori testing and treatment, in discontinuing maintenance therapy. Patients were included from seven general practices, who had been using acid-inhibiting medication for more than 3 months in the period May 1996-May 1997. Patients with a history of proven peptic ulcer disease were tested, and treated with proton pump inhibitor-triple therapy if positive. Maintenance therapy was discontinued and restart within 12 months was monitored. Long-term acid suppression was used by 2.8% of the practice-populations. A peptic ulcer disease history was found in 18% of the patients, 73% of whom were offered the 'H. pylori test and treat' alternative. The majority responded: 92% of the H. pylori-infected patients were treated, 78% of whom successfully discontinued long-term medication. Implementing an 'H. pylori test and treat' strategy enabled one-third of the patients with a peptic ulcer disease history to stop maintenance therapy successfully. The strategy contributes to reduction of long-term drug use, but compliance needs improvement.
- 28 March 1998
- Vol. 316 (7136) , 1020
Smoking, alcohol and coffee consumption, and H pylori infection. Cross sectional study shows no protective effect of alcohol.
- 28 March 1998
- Vol. 316 (7136) , 1020
Smoking, alcohol and coffee consumption, and H pylori infection. Cross sectional study shows no protective effect of alcohol.
Smoking, alcohol and coffee consumption, and H pylori infection
# Alcohol consumption eliminates rather than prevents infection with H pylori {#article-title-2} EDITOR—Brenner et al conclude that alcohol consumption may have a protective effect against infection with Helicobacter pylori .1 H pylori infection is commonly acquired during childhood and spontaneous elimination may occur, usually in young children and elderly people, but it may be acquired and eliminated spontaneously throughout adulthood.2 Drinking alcohol is usually an adult habit, and if alcohol does have a protective effect against infection with H pylori we can assume that it eradicates the infection rather than prevents it. Alcohol consumption may therefore have a role only in those few people in whom spontaneous elimination of the bacterium is thought to have occurred.2 If alcohol does protect against H pylori infection then the number of years for which it has been consumed is probably important, and not just the amount consumed, particularly when overall consumption is low. Brenner et al do not, however, give data on lifetime alcohol consumption in their series. Finally, socioeconomic factors in childhood, such as low social class, manual occupation of the parents, and measures of crowding have been consistently identified as major risk factors for infection with H pylori ,3 but they were not adjusted for in the multivariate analysis in the authors' study. We recently conducted a seroepidemiological study of H pylori infection in 705 residents in the rural town of Cirò, a wine producing centre in southern Italy.4 A structured questionnaire was administered to all subjects. The table shows …
Smoking, alcohol and coffee consumption, and H pylori infection
# Alcohol consumption eliminates rather than prevents infection with H pylori {#article-title-2} EDITOR—Brenner et al conclude that alcohol consumption may have a protective effect against infection with Helicobacter pylori .1 H pylori infection is commonly acquired during childhood and spontaneous elimination may occur, usually in young children and elderly people, but it may be acquired and eliminated spontaneously throughout adulthood.2 Drinking alcohol is usually an adult habit, and if alcohol does have a protective effect against infection with H pylori we can assume that it eradicates the infection rather than prevents it. Alcohol consumption may therefore have a role only in those few people in whom spontaneous elimination of the bacterium is thought to have occurred.2 If alcohol does protect against H pylori infection then the number of years for which it has been consumed is probably important, and not just the amount consumed, particularly when overall consumption is low. Brenner et al do not, however, give data on lifetime alcohol consumption in their series. Finally, socioeconomic factors in childhood, such as low social class, manual occupation of the parents, and measures of crowding have been consistently identified as major risk factors for infection with H pylori ,3 but they were not adjusted for in the multivariate analysis in the authors' study. We recently conducted a seroepidemiological study of H pylori infection in 705 residents in the rural town of Cirò, a wine producing centre in southern Italy.4 A structured questionnaire was administered to all subjects. The table shows …